Structures by: Amirthaganesan S.
Total: 6
N-[4-Acetyl-5-(3-methoxyphenyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl]acetamide
C13H15N3O3S
Acta Crystallographica Section E (2008) 64, 11 o2096
a=11.3790(4)Å b=10.5993(3)Å c=11.9596(2)Å
α=90.00° β=108.225(2)° γ=90.00°
2,4-Bis(4-bromophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19Br2NO
Acta Crystallographica Section E (2009) 65, 6 o1356
a=6.9415(3)Å b=10.4489(4)Å c=13.2888(5)Å
α=101.542(2)° β=100.391(2)° γ=94.472(2)°
Ethyl 4-(3-chlorophenyl)-3,6-dihydroxy-6-methyl-2-(2-pyridyl)-4,5,6,7- tetrahydroindazole-5-carboxylate
C22H22ClN3O4
Acta Crystallographica Section E (2010) 66, 4 o861
a=8.585(5)Å b=9.053(3)Å c=14.884(3)Å
α=94.68(2)° β=90.19(2)° γ=115.66(3)°
Dimethyl 2-(3-chlorophenyl)-6-hydroxy-6-methyl-4-(methylamino)cyclohex-3-ene- 1,3-dicarboxylate
C18H22ClNO5
Acta Crystallographica Section E (2011) 67, 6 o1424
a=11.962(3)Å b=9.118(4)Å c=17.704(5)Å
α=90.00° β=104.890(3)° γ=90.00°
Isopropyl 1-benzoyl-4-benzoyloxy-2,6-diphenyl-1,2,3,6-tetrahydropyridine-3-carboxylate
C35H31NO5
Acta Crystallographica Section E (2014) 70, 8 o854
a=10.1788(6)Å b=11.4325(7)Å c=13.1395(9)Å
α=81.847(2)° β=86.662(3)° γ=69.654(2)°
<i>N</i>-[(1<i>E</i>)-5-(3-Chlorophenyl)-3-methylcyclohex-2-en-1-ylidene]hydroxylamine
C13H14ClNO
Acta Crystallographica Section E (2013) 69, 3 o449
a=19.7898(8)Å b=19.7898(8)Å c=12.4416(11)Å
α=90.00° β=90.00° γ=90.00°